The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
bluebird bio, Inc(NASDAQ:BLUE) 
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent -thalassemia; Len...
Website: http://www.bluebirdbio.com
Founded: 1992
Full Time Employees: 1,171
Sector: Healthcare
Industry: Biotechnology
bluebird bio Days Payable Outstanding ttm (DPO)
bluebird bio Days Receivable Outstanding ttm (DSO)
bluebird bio Days Inventory Outstanding ttm (DIO)
bluebird bio Op Cashflow Per Share ttm
bluebird bio Free Cashflow Per Share ttm
bluebird bio Cash Per Share ttm
bluebird bio P/S ratio ttm
bluebird bio (GAAP) P/E ratio ttm
bluebird bio P/B ratio ttm
No extra charts and metrics for this ticker.